The Mechanisms of PML-Nuclear Body Formation (DOI:10.1016/j.molcel.2006.09.013);The Mechanisms of PML-Nuclear Body Formation

Molecular Cell

Volumn 24, Issue 3, 2006, Pages 331-339

  Shen, Tian Huai ^a   Lin, Hui Kuan ^a   Scaglioni, Pier Paolo ^a   Yung, Thomas M ^a   Pandolfi, Pier Paolo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CELLBIO; PROTEINS

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; SUMO PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; COVALENT BOND; EMBRYO; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; VIRUS INFECTION;

EID: 33750447586     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.11.010     Document Type: Erratum

References (27)

1. Bernardi R., and Pandolfi P.P. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22 (2003) 9048-9057
2. Bernardi R., Scaglioni P.P., Bergmann S., Horn H.F., Vousden K.H., and Pandolfi P.P. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. 6 (2004) 665-672
3. Boddy M.N., Howe K., Etkin L.D., Solomon E., and Freemont P.S. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13 (1996) 971-982
4. Boisvert F.M., Hendzel M.J., and Bazett-Jones D.P. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148 (2000) 283-292
5. Dellaire G., Eskiw C.H., Dehghani H., Ching R.W., and Bazett-Jones D.P. Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1. J. Cell Sci. 119 (2006) 1034-1042
6. Everett R.D., Lomonte P., Sternsdorf T., van Driel R., and Orr A. Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112 (1999) 4581-4588
7. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?. Genes Dev. 18 (2004) 2046-2059
8. Gurrieri C., Capodieci P., Bernardi R., Scaglioni P.P., Nafa K., Rush L.J., Verbel D.A., Cordon-Cardo C., and Pandolfi P.P. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 96 (2004) 269-279
9. Hannich J.T., Lewis A., Kroetz M.B., Li S.J., Heide H., Emili A., and Hochstrasser M. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280 (2005) 4102-4110
10. Hofmann T.G., and Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10 (2003) 1290-1299
11. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss III J.F., and Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147 (1999) 221-234
12. Jensen K., Shiels C., and Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20 (2001) 7223-7233
13. Koken M.H., Puvion-Dutilleul F., Guillemin M.C., Viron A., Linares-Cruz G., Stuurman N., de Jong L., Szostecki C., Calvo F., Chomienne C., et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13 (1994) 1073-1083
14. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., Duprez E., Pandolfi P.P., Puvion E., Freemont P., and de The H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193 (2001) 1361-1371
15. Lin D.-Y., Huang Y.-S., Jeng J.-C., Kuo H.-Y., Chang C.-C., Chao T.-T., Ho C.-C., Chen Y.-C., Lin T.-P., Fang H.-I., et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24 (2006) 355-366 this issue
16. Lin H.K., Bergmann S., and Pandolfi P.P. Cytoplasmic PML function in TGF-beta signalling. Nature 431 (2004) 205-211
17. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., and Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96 (1999) 11364-11369
18. Minty A., Dumont X., Kaghad M., and Caput D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275 (2000) 36316-36323
19. Pandolfi P.P. In vivo analysis of the molecular genetics of acute promyelocytic leukemia. Oncogene 20 (2001) 5726-5735
20. Quimby B.B., Yong-Gonzalez V., Anan T., Strunnikov A.V., and Dasso M. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast. Oncogene 25 (2006) 2999-3005
21. Reverter D., and Lima C.D. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435 (2005) 687-692
22. Salomoni P., and Pandolfi P.P. The role of PML in tumor suppression. Cell 108 (2002) 165-170
23. Seeler J.S., and Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4 (2003) 690-699
24. Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., and Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA 101 (2004) 14373-14378
25. Wang Z.G., Delva L., Gaboli M., Rivi R., Giorgio M., Cordon-Cardo C., Grosveld F., and Pandolfi P.P. Role of PML in cell growth and the retinoic acid pathway. Science 279 (1998) 1547-1551
26. Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., and Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 95 (2000) 2748-2752
27. Zhong S., Salomoni P., and Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2 (2000) E85-E90